HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemosensitivity of human bladder cancer cells in long-term culture and clinical responses to the selected anticancer drug.

Abstract
In vitro sensitivity of an established cell line from human urinary bladder cancer to various chemotherapeutic agents was determined by 14C-leucine incorporation into the target cells. Of 12 drugs tested, Carboquone, Neocarzinostatin, Actinomycin D, Adriamycin, Mitomycin C and Chromomycin A3 produced intensive cytotoxic effects, while Thio-Tepa, Bleomycin, 5-Fluorouracil and Vincirstine were less cytotoxic, Intravesical instillation of Carboquone, one of the most toxic agents in vitro, resulted in complete or partial tumor remission in 6 of 9 patients with bladder cancer. Prophylactic effects of periodic intravesical Carboquone were also indicated in 7 of 8 patients who had experienced recurring superficial bladder tumors.
AuthorsT Kato, R Nemoto, T Nishimoto, I Kumagai, K Miura
JournalCancer (Cancer) Vol. 44 Issue 1 Pg. 58-63 (Jul 1979) ISSN: 0008-543X [Print] United States
PMID455264 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Azirines
  • Carbazilquinone
Topics
  • Antineoplastic Agents (administration & dosage, pharmacology)
  • Azirines (pharmacology)
  • Carbazilquinone (administration & dosage, pharmacology)
  • Carcinoma, Transitional Cell (drug therapy)
  • Cell Line
  • Cell Survival (drug effects)
  • Drug Evaluation, Preclinical
  • Drug Resistance
  • Humans
  • Neoplasms, Experimental (drug therapy)
  • Remission, Spontaneous
  • Urinary Bladder Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: